Celcuity at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
Celcuity brings 1 presentation to SABCS 2026 in San Antonio, and exhibits at Booth 1510. The drug developer presents nonclinical work on overcoming resistance to endocrine therapy and CDK4/6 inhibitors in HR-positive disease.
| Organization | SABCS 2026 Attendance |
|---|---|
Celcuity Minneapolis, MN | |
Clinical-stage company developing gedatolisib, a PI3K/mTOR pathway inhibitor, for HR+/HER2- advanced breast cancer. | Booth Exhibiting at Booth 1510 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Find decision makers at Celcuity
Tell us what you sell and we’ll find the people at Celcuity most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction